,

Trial of the Week: SOAP II References

Jessica Casey joins to discuss the April Trial of the Week “Comparison of Dopamine and Norepinephrine in the Treatment of Shock,” the SOAP II study.

Jessica Casey, PharmD, BCPS, BCCP joins the podcast to do a deep-dive into an April Trial of the Week AND the 2024 Critical Care Trials March Madness bracket National Champion, the SOAP II study.

“Comparison of Dopamine and Norepinephrine in the Treatment of Shock,” the SOAP II study was published in NEJM in 2010. We set the scene by reviewing catecholamine vasopressor receptor physiology, guideline recommendations, and pre-SOAP II research. Then we do a deep dive into the SOAP II trial of the week. Did including all forms of shock help or hurt? How does the mortality in this study compare with others? Would this have been as positive of a study in 2024? What do the guidelines recommend now? Is dopamine dead? Will anyone take norepinephrine’s throne? Jessica and I review trial fun facts, stand-out supplementary materials, and much, much more.

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.